BECTON DICKINSON AND CO (1BDX.MI) Stock Price, Forecast & Analysis

BIT:1BDX • US0758871091

156.7 EUR
-8.05 (-4.89%)
Last: Oct 30, 2025, 07:00 PM

1BDX.MI Key Statistics, Chart & Performance

Key Statistics
Market Cap44.91B
Revenue(TTM)21.84B
Net Income(TTM)1.68B
Shares286.63M
Float284.96M
52 Week HighN/A
52 Week LowN/A
Yearly Dividend3.28
Dividend Yield2.37%
EPS(TTM)12.47
PE12.57
Fwd PE12.09
Earnings (Next)02-03
IPO1963-09-25
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
1BDX.MI short term performance overview.The bars show the price performance of 1BDX.MI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months

1BDX.MI long term performance overview.The bars show the price performance of 1BDX.MI in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of 1BDX.MI is 156.7 EUR.

BECTON DICKINSON AND CO / 1BDX Daily stock chart

1BDX.MI Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to 1BDX.MI.


Chartmill TA Rating
Chartmill Setup Rating
1BDX.MI Full Technical Analysis Report

1BDX.MI Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to 1BDX.MI. 1BDX.MI has a medium profitability rating, but doesn't score so well on its financial health evaluation.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
1BDX.MI Full Fundamental Analysis Report

1BDX.MI Financial Highlights

Over the last trailing twelve months 1BDX.MI reported a non-GAAP Earnings per Share(EPS) of 12.47. The EPS increased by 9.57% compared to the year before.


Industry RankSector Rank
PM (TTM) 7.68%
ROA 3.03%
ROE 6.61%
Debt/Equity 0.69
Chartmill High Growth Momentum
EPS Q2Q%3.94%
Sales Q2Q%8.33%
EPS 1Y (TTM)9.57%
Revenue 1Y (TTM)8.23%
1BDX.MI financials

1BDX.MI Forecast & Estimates

19 analysts have analysed 1BDX.MI and the average price target is 190.9 EUR. This implies a price increase of 21.83% is expected in the next year compared to the current price of 156.7.

For the next year, analysts expect an EPS growth of 3.94% and a revenue growth 4.3% for 1BDX.MI


Analysts
Analysts72.63
Price Target190.9 (21.83%)
EPS Next Y3.94%
Revenue Next Year4.3%
1BDX.MI Analyst Estimates1BDX.MI Analyst Ratings

1BDX.MI Ownership

Ownership
Inst Owners92.24%
Ins Owners0.57%
Short Float %N/A
Short RatioN/A
1BDX.MI Ownership

1BDX.MI Competitors/Peers

The largest stocks on the EU markets in the "Health Care Equipment" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
1MDT MEDTRONIC PLC16.05108.279B
2M6 MEDTRONIC PLC15.73106.586B
SHL SIEMENS HEALTHINEERS AG15.8346.756B
1PHIA KONINKLIJKE PHILIPS NV17.3825.46B
PHI1 KONINKLIJKE PHILIPS NV17.3125.287B
PHIA KONINKLIJKE PHILIPS NV17.3525.277B
BIM BIOMERIEUX19.0311.161B
DIA DIASORIN SPA17.173.866B
OBCK OTTOBOCK SE & CO KGAA18.423.663B
AFX CARL ZEISS MEDITEC AG - BR11.42.415B

About 1BDX.MI

Company Profile

1BDX logo image Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company is headquartered in Franklin Lakes, New Jersey and currently employs 74,000 full-time employees. The firm is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.

Company Info

BECTON DICKINSON AND CO

One Becton Drive

Franklin Lakes NEW JERSEY US

Employees: 74000

1BDX Company Website

1BDX Investor Relations

Phone: 12018476800

BECTON DICKINSON AND CO / 1BDX.MI FAQ

Can you describe the business of BECTON DICKINSON AND CO?

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company is headquartered in Franklin Lakes, New Jersey and currently employs 74,000 full-time employees. The firm is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.


What is the current price of 1BDX stock?

The current stock price of 1BDX.MI is 156.7 EUR. The price decreased by -4.89% in the last trading session.


Does 1BDX stock pay dividends?

BECTON DICKINSON AND CO (1BDX.MI) has a dividend yield of 2.37%. The yearly dividend amount is currently 3.28.


How is the ChartMill rating for BECTON DICKINSON AND CO?

1BDX.MI has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


How is the valuation of BECTON DICKINSON AND CO (1BDX.MI) based on its PE ratio?

The PE ratio for BECTON DICKINSON AND CO (1BDX.MI) is 12.57. This is based on the reported non-GAAP earnings per share of 12.47 and the current share price of 156.7 EUR.


How many employees does BECTON DICKINSON AND CO have?

BECTON DICKINSON AND CO (1BDX.MI) currently has 74000 employees.


What is the market capitalization of 1BDX stock?

BECTON DICKINSON AND CO (1BDX.MI) has a market capitalization of 44.91B EUR. This makes 1BDX.MI a Large Cap stock.